{
    "eid": "2-s2.0-85151208998",
    "title": "A Novel and Simplified Score for Determining Treatment Eligibility for Patients with Chronic Hepatitis B",
    "cover-date": "2023-03-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Virology",
            "@code": "2406",
            "@abbrev": "IMMU"
        }
    ],
    "keywords": [
        "hepatitis b",
        "score",
        "simplification",
        "Thailand",
        "treatment"
    ],
    "authors": [
        "Tanawat Geeratragool",
        "Pisit Tangkijvanich",
        "Supot Nimanong",
        "Siwaporn Chainuvati",
        "Phunchai Charatcharoenwitthaya",
        "Tawesak Tanwandee",
        "Watcharasak Chotiyaputta"
    ],
    "citedby-count": 1,
    "ref-count": 32,
    "ref-list": [
        "Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: A modelling study",
        "Access to Treatment for Hepatitis B Virus Infection\u2014Worldwide, 2016",
        "Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance",
        "EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection",
        "Asian-Pacific clinical practice guidelines on the management of hepatitis B: A 2015 update",
        "Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in Africa",
        "Validation of the TREAT-B score for hepatitis B treatment eligibility in a large Asian cohort: TREAT-B improves with age",
        "Clinical utility of TREAT-B score in African and non-African HBV-infected patients living in Europe",
        "Performance of two simplified HBV treatment criteria (TREAT-B score and WHO guidelines) in Burkina Faso, West Africa",
        "A novel score to select patients for treatment in chronic hepatitis B: Results from a large Ethiopian cohort",
        "Eligibility for hepatitis B antiviral therapy among adults in the general population in Zambia",
        "Assessment and Simplification of Treatment Eligibility Among Patients With Chronic Hepatitis B Infection in Vietnam",
        "Reply to: \u201cValidation of the TREAT-B score for hepatitis B treatment eligibility in a large Asian cohort: TREAT-B improves with age",
        "Natural history of chronic HBV infection in West Africa: A longitudinal population-based study from The Gambia",
        "Natural history and clinical management of chronic hepatitis B virus infection in children",
        "Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): Development and validation of a predictive score",
        "Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers",
        "Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B",
        "Presentation of multivariate data for clinical use: The Framingham Study risk score functions",
        "Receiver operating characteristic curve: Overview and practical use for clinicians",
        "Diagnostic Testing Accuracy: Sensitivity, Specificity, Predictive Values and Likelihood Ratios",
        "PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy",
        "Modified PAGE-B score predicts the risk of hepatocellular carcinoma in Asians with chronic hepatitis B on antiviral therapy",
        "Toronto HCC risk index: A validated scoring system to predict 10-year risk of HCC in patients with cirrhosis",
        "Global perspective on the natural history of chronic hepatitis B: Role of hepatitis B virus genotypes A to J",
        "Do we need to determine viral genotype in treating chronic hepatitis B?",
        "Geographic variation in viral load among hepatitis B carriers with differing risks of hepatocellular carcinoma",
        "Profiles of HBV DNA in a large population of Chinese patients with chronic hepatitis B: Implications for antiviral therapy"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}